Indrayani Biotech Limited

BSE:526445 Stock Report

Market Cap: ₹1.3b

Indrayani Biotech Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Kasiraman Sundar

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure7yrs
CEO ownership5.8%
Management average tenure4.3yrs
Board average tenure5.5yrs

Recent management updates

Recent updates

CEO

Kasiraman Sundar (63 yo)

7yrs

Tenure

Mr. Kasiraman Sayee Sundar has been Executive Director and Managing Director of Indrayani Biotech Ltd since February 17, 2018. He has experience in Real Time Embedded Systems & Firmware Development and was...

Leadership Team

NamePositionTenureCompensationOwnership
Kasiraman Sundar
MD & Executive Director7yrsno data5.78%
₹ 77.1m
Singarababu Indirakumar
Whole Time Director4.5yrs₹1.83mno data
G. Swaminathan
Whole-Time Director4.5yrsno data9.09%
₹ 121.3m
Muthukrishnan Ramesh
Whole Time Director3.8yrs₹2.82m2.31%
₹ 30.8m
Vinayaka Bodala
Chief Financial Officer4.1yrsno datano data
V. Santhanakrishnan
Company Secretary & Compliance Officer1.1yrsno datano data
Mary Sujatha
Head of Human Resourceno datano datano data
Dhinakaran Rajagopal
Chief Co-ordinating Officerno datano datano data

4.3yrs

Average Tenure

56.5yo

Average Age

Experienced Management: 526445's management team is considered experienced (4.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Kasiraman Sundar
MD & Executive Director7yrsno data5.78%
₹ 77.1m
Singarababu Indirakumar
Whole Time Director4.5yrs₹1.83mno data
G. Swaminathan
Whole-Time Director4.5yrsno data9.09%
₹ 121.3m
Muthukrishnan Ramesh
Whole Time Director4.1yrs₹2.82m2.31%
₹ 30.8m
Nangavaram Ranganathan
Independent Chairman of the Board6.5yrsno datano data
Kannimangalam Vaidyanathan
Independent Director6.5yrsno data0.022%
₹ 292.9k
Lakshmiprabha Kasiraman
Non Independent Non-Executive Women Director6.5yrsno data0.0077%
₹ 102.6k
Bokara Nagarajan Priyadharshini
Independent Director3.9yrsno datano data

5.5yrs

Average Tenure

61yo

Average Age

Experienced Board: 526445's board of directors are considered experienced (5.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/01 04:34
End of Day Share Price 2025/01/31 00:00
Earnings2024/06/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Indrayani Biotech Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution